Valuation
- Market cap
- 1,329,000
- Revenue TTM
- $4,730,000
- Net income TTM
- $9,880,000
- PE ratio
- 0.00
- Forward PE
- 0.00
- Profit margin
- 208.88%
- Debt to equity
- 0.00
Trading
- Volume
- 1,089,600
- Avg volume
- 1,650,822
- Day's range
- $1.18 – $1.68
- Shares out
- 8,922,000
- Stochastic %K
- 19%
- Beta
- 0.07
- Analysts
- Strong Buy
- Price target
- $127.10
Company profile
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sp...
Show more
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company provides its services through clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.
- Industry
- Medical Care Facilities
- Sector
- Healthcare
- Website
- https://www.nivf.global
- Address
- PS Tower,36/39-36/40, 13th Floor Sukhumvit 21 Road (Asoke) Khlong Toei Nuea Sub-dist, Watthana Dist, Bangkok, Thailand
Latest news
No headlines yet.
